Director, Medical Affairs

Gilead Sciences•Foster City, CA

1d•$243,100 - $314,600

About The Position

At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. Provides strategic medical leadership for inflammation pipeline assets—bringing scientific insight, evidence generation, and external perspectives to the decisions that shape development and long-term value. Leads through influence in a matrixed environment and represents Global Medical Affairs in early and mid-stage governance forums.

Requirements

12+ years of relevant experience with Bachelors degree or 8+ years of relevant experience with Advanced scientific degree (e.g. MD, PharmD, PhD)
Advanced clinical and/or scientific knowledge in rheumatology, inflammatory bowel disease, immunology, or other inflammatory disease areas
Relevant pharmaceutical company experience within Medical Affairs or clinical development-adjacent roles, with strong understanding of global development and access considerations
Proven ability to lead cross‑functional strategy in a complex matrix.
Ability to synthesize findings and clearly articulate implications from multiple sources of information, and to formulate strong, actionable recommendations.
Works independently with minimal supervision
Ability to embrace Gilead’s patient-centric values, including highest ethical and compliance standards

Nice To Haves

Experience influencing early asset strategy and portfolio decisions preferred
Global scope experience preferred

Responsibilities

Owns the global medical strategy for assigned inflammation pipeline assets across early and mid‑stage development.
Serves as Medical Affairs asset lead, delivering objective scientific input to disease strategy, target product profile, trial/endpoint design, go/no‑go criteria, and lifecycle sequencing.
Anchors development plans in unmet medical need and future evidence requirements.
Leads the medical evidence and scientific communication strategy, including integrated evidence plans, early medical narratives, publication planning, and core scientific platforms.
Aligns clinical data generation with external engagement and value/access evidence needs.
Identifies and maps external experts across priority disease areas.
Builds and maintains credible, ethical scientific partnerships to inform development strategy, disease/treatment landscape insights, and patient/payer evidence expectations.
Represents Gilead as a scientific ambassador in early pipeline settings.
Represents Global Medical Affairs on Development Project Teams, governance forums, and key decision bodies.
Partners with Clinical Development/Early Research, Global Strategic Marketing, Global Value & Access, Regulatory, and other cross‑functional teams to advance pipeline assets.
Ensures medical insight is integrated early, consistently, and with clear decision impact.
Provides medical due diligence to support business development and partnering evaluations.
Shapes portfolio discussions by articulating scientific differentiation, evidence risk, and opportunity.
Surfaces external opportunities aligned with Gilead’s inflammation strategy.
Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.
Develop Talent - understand the skills, experience, aspirations and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop and realize their purpose.
Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives, and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.